About Central States Research
Clinical Trials at Central States Research
During the past decade, Central States Research conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 5 clinical trials were completed, i.e. on
average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Central States Research" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Celgene" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Zynerba Pharmaceuticals, Inc." with 3 trials sponsored and "Biohaven Pharmaceuticals, Inc."
with 3 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Central States Research"
#1 collaborator was "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator and "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Central States Research
According to Clinical.Site data, the most researched conditions in "Central States Research" are
"Alzheimer Disease" (4 trials), "Alzheimer's Disease" (3 trials), "Atopic Dermatitis" (3 trials), "Crohn Disease" (3 trials) and "Fragile X Syndrome" (3 trials). Many other conditions were trialed in "Central States Research" in a lesser frequency.
Clinical Trials Intervention Types at Central States Research
Most popular intervention types in "Central States Research" are "Drug" (21 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Lebrikizumab" (3 trials), "Ozanimod" (3 trials), "Donanemab" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Central States Research
The vast majority of trials in "Central States Research" are
24 trials for "All" genders.
Clinical Trials Status at Central States Research
Currently, there are NaN active trials in "Central States Research".
undefined are not yet recruiting,
8 are recruiting,
3 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 9 completed trials in Central States Research,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Central States Research, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".